Islet cell tumors, also known as pancreatic neuroendocrine tumors or pancreatic islet cell tumors, are a type of rare cancer that develops in the islet cells of the pancreas. Islet cells are responsible for producing various hormones that regulate blood sugar levels, such as insulin and glucagon.
Islet cell tumors can be either benign (non-cancerous) or malignant (cancerous). Benign tumors are more common and often do not cause any symptoms or health problems. Malignant tumors, on the other hand, can grow and spread to other parts of the body, potentially causing serious complications.
Symptoms of islet cell tumors may vary depending on the type and location of the tumor. Common signs and symptoms include abdominal pain, weight loss, changes in blood sugar levels (hypoglycemia or hyperglycemia), diarrhea, flushing, and jaundice.
Diagnosis of islet cell tumors often involves a combination of imaging tests, such as CT scan or MRI, blood tests to measure hormone levels, and sometimes a biopsy to confirm the presence of cancer cells.
Treatment for islet cell tumors depends on several factors, including the size and location of the tumor, whether it is benign or malignant, and overall health. Options may include surgical removal of the tumor, chemotherapy, radiation therapy, targeted therapy, and hormone therapy.
Regular follow-ups and monitoring are important for people with islet cell tumors, as they can recur or spread even after treatment. The prognosis and outlook for individuals with islet cell tumors can vary widely but early detection and intervention can significantly improve the chances of a successful outcome.
